alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Driss Chaouni, Respondent, v Shajahan Ali, Defendant, and Dial 7 Car and Limousine Service, Inc., Appellant.

[963 NYS2d 27]

(Ben R. Barbato, J.),

Order, Supreme Court, Bronx County entered March 1, 2012, which, insofar as appealed from, denied defendant Dial 7 Car and Limousine Service, Inc.’s (Dial 7) motion for summary judgment dismissing the complaint as against it, unanimously reversed, on the law, without costs, and the motion granted. Appeal from order, same court and Justice, entered on or about May 15, 2012, which denied Dial 7’s motion for leave to reargue, unanimously dismissed, without costs, as taken from a nonappealable order. The Clerk is directed to enter judgment accordingly.

Supreme Court should have granted Dial 7’s motion to dismiss because it established that it could not be held liable for defend*425ant Shajahan Ali’s conduct, as he was an independent contractor and not Dial 7’s employee. Dial 7 submitted a host of evidence showing that it did not control the method or means by which Ali’s work was to be performed *(see Matter of O’Brien v Spitzer,*7 NY3d 239, 242 [2006]; *Anikushina v Moodie,*58 AD3d 501, 504 [1st Dept 2009], *lv dismissed*12 NY3d 905 [2009]). The undisputed evidence showed that Dial 7’s drivers own their own vehicles, were responsible for the maintenance thereof, paid for the insurance, and had unfettered discretion to determine the days and times they worked, with no minimum or maximum number of hours or days imposed by Dial 7. Dial 7 does not require its drivers to wear a uniform nor does it have a dress code, and its drivers are free to accept or reject any dispatch as they like, can take breaks or end their shifts whenever they want, and are even permitted to work for other livery base stations. Dial 7’s drivers kept a fixed percentage of all fares and 100% of all tips, and Dial 7 did not withhold taxes and issued 1099 forms, not W-2 forms, to its drivers *(see Barak v Chen,*87 AD3d 955 [2d Dept 2011]; *Abouzeid v Grgas,*295 AD2d 376, 377-378 [2d Dept 2002]).

While there was evidence that Dial 7 would inspect Ali’s vehicle on a weekly basis, and that it could accept credit card payments via telephone, this is insufficient to raise an issue of fact and is indicative of mere incidental or “general supervisory control” that does not rise to the level of an employer-employee relationship *(Bizjak v Gramercy Capital Corp.,*95 AD3d 469, 470 [1st Dept 2012]; *see Matter of Hertz Corp. [Commissioner of Labor],*2 NY3d 733, 735 [2004]; *Holcomb v TWR Express, Inc.,*11 AD3d 513, 514 [2d Dept 2004]).

We dismiss the appeal from the May 15, 2012 order since no appeal lies from the denial of reargument, and the appeal is otherwise academic in light of our reversal of the prior order.

Concur—Friedman, J.E, Sweeny, Renwick, Richter and Román, JJ.
EXHIBIT
32








STATEMENT
REQUIRED BY 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report on Form 10-QSB/A of China Digital Media
Corporation (the "Company") for the three months ended September 30, 2007,
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Daniel Ng, Chief Executive Officer and Chief Financial Officer of
the Company, certifies that:





·
            the
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





·
            information
      contained in the Report fairly presents, in all material respects, the
      financial condition and results of operations of the Company on the dates
      and for the periods presented.








/s/
      Ng Chi ShingNg
      Chi ShingDirector,
      President, Chief Executive Officer/s/
      Ng Chi ShingNg
      Chi ShingChief
      Financial OfficerMay
      6, 2008








This
certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as
amended.
Cite as 2023 Ark. 5

SUPREME COURT OF ARKANSAS

IN RE ARKANSAS STATE BOARD OF 

LAW EXAMINERS

Opinion Delivered: January 26, 2023

PER CURIAM

Allison Plowman Hatfield of Little Rock is appointed to the Arkansas State Board of 

Law Examiners for a six-year term concluding on January 26, 2029. Ms. Hatfield will be an 

at-large representative; she replaces Judge Waymond Brown, whose term has concluded.

The court extends its sincere appreciation to Ms. Hatfield for accepting appointment 

to this important board. The court also expresses its gratitude to Judge Brown for his 

dedicated service to the board.
# Bureau of Indian Affairs

BIA IFPM Position Crosswalk

Bureau of Indian Affairs Implementation Memo (9/2/04)

## Interagency Fire Program Management

-  IFPM Standard 
-  Human Resources 
-  Fire Management 
-  Agency Specific    -  BIA 
  -  BLM 
  -  FS 
  -  FWS 
  -  NPS 
-  Archives 
-  Contacts
#### In the Matter of Carlos Abreu, Appellant, v Michael F. Hogan, as Commissioner of Mental Health, et al., Respondents.

Decided September 21, 2010

Appeal dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that the order appealed from does not finally determine the proceeding within the meaning of the Constitution.
II 

111TH CONGRESS 

1ST SESSION S. 2621 

To suspend temporarily the duty on 4-Methylbenzenesulfonamide. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 2, 2009 

Mr. SCHUMER introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on 4- 

Methylbenzenesulfonamide. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 4-METHYLBENZENESULFONAMIDE. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 4-Methylbenzenesulfonamide 

(CAS No. 70–55–3) (provided for in subheading 

2935.00.95) ........................... Free No change No change On or before 

12/31/2011 ’’. 


tjames on DSKG8SOYB1PROD with BILLS
2 

•S 2621 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of enactment of this Act. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 10-1391

MAGDALINE IYABO BANYONG,

Petitioner,

v.

ERIC H. HOLDER, JR., Attorney General,

Respondent.

On Petition for Review of an Order of the Board of Immigration 

Appeals.

Submitted: November 22, 2010 Decided: December 9, 2010

Before SHEDD, DUNCAN, and WYNN, Circuit Judges.

Petition denied by unpublished per curiam opinion.

Kim-Bun Thomas Li, LI, LATSEY & GUITERMAN, PLLC, Rockville, 

Maryland, for Petitioner. Tony West, Assistant Attorney General, 

Daniel E. Goldman, Senior Litigation Counsel, Jem C. Sponzo, 

Office of Immigration Litigation, UNITED STATES DEPARTMENT OF 

JUSTICE, Washington, D.C., for Respondent.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Magdaline Iyabo Banyong, a native and citizen of 

Cameroon, petitions for review of an order of the Board of 

Immigration Appeals (Board) denying her motion to reconsider. 

We have reviewed the administrative record and find no abuse of 

discretion in the denial of relief on Banyong’s motion. See 8 

C.F.R. § 1003.2(a) (2010). We accordingly deny the petition for 

review for the reasons stated by the Board. See In re: Banyong

(B.I.A. Mar. 8, 2010). We dispense with oral argument because 

the facts and legal contentions are adequately presented in the 

materials before the court and argument would not aid the 

decisional process.

PETITION DENIED
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2577 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2577

             To suspend temporarily the duty on Potassium 
            decafluoro(pentafluorethyl)cyclohexanesulfonate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 30, 2009

   Mr. Bond introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
             To suspend temporarily the duty on Potassium 
            decafluoro(pentafluorethyl)cyclohexanesulfonate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. POTASSIUM DECAFLUORO(PENTAFLUORO-
              ETHYL)CYCLOHEXANESULFONATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Potassium           Free         No change        No change        On or before 12/  ''.
                        decafluoro(pentaf                                                  31/2011.......
                        luorethyl)
                        cyclohexanesulfon
                        ate (CAS No.
                        67584-42-3)
                        (provided for in
                        subheading
                        2904.90.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
# **EXHIBIT 32.2**

# ** **

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for thefiscal quarter ended June 30, 2005 (the “Report”) by BentleyPharmaceuticals, Inc. (the “Registrant”), the undersigned hereby certifiesthat, to his knowledge:

 

1.     TheReport fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934, as amended, and

 

2.     Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Registrant.

 

 
|   | /s/ Michael D. Price                          |   |
|--------|-----------------------------------------------|--------|
|   | Michael D. Price                              |
|   | Vice President, Chief Financial               |
|   | Officer, Treasurer and Secretary              |
|   | (Principal Financial and Accounting  Officer) |
|   |                                          |
|   | August 9, 2005                           |

 

----
#### The People of the State of New York, Respondent, v Alexander L. Crump, Appellant.

[976 NYS2d 411]

Appeal by the defendant from a judgment of the Supreme Court, Suffolk County (J. Doyle, J.), rendered September 28, 2011, convicting him of criminal possession of a controlled substance in the seventh degree, upon his plea of guilty, and imposing sentence.

Ordered that the judgment is affirmed.

The defendant correctly contends that his waiver of the right to appeal was invalid *(see People v Lopez,*6 NY3d 248 [2006]). However, contrary to the defendant’s contention, the accusatory instrument adequately apprised the defendant of the particular crime with which he was being charged *(see People v Dreyden,*15 NY3d 100, 103 [2010]; *People v Casey,*95 NY2d 354, 360 [2000]). The defendant’s nonjurisdictional challenges to the accusatory instrument were forfeited by his plea of guilty *(see People v Beattie,*80 NY2d 840, 842 [1992]; *People v Gould,*242 AD2d 583, 584 [1997]).

The defendant was not denied the effective assistance of counsel *(see People v Benevento,*91 NY2d 708, 712 [1998]; *People v Baldi,*54 NY2d 137, 147 [1981]). Skelos, J.E, Dickerson, Lott and Austin, JJ., concur.
-  Home 
        -  News 
        -  Media Library 
        -  Media Asset Details 

Return to Media Library Search Results

# National Donor Day

View full-sized image
                Download Media **Please credit each image as: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

## Description

                    Illustrations of body organs.                

## Alternate Text

Several illustrated organs with the title: National Donor Day.

## File Size

45 KB | 1080 x 1080

## File Type

JPG

## Related Keywords

Anatomy

Share this page
FacebookXEmailWhatsAppLinkedInRedditPinterest
Exhibit 32.1
 CERTIFICATION 1
  1.
 2.   Dated: May 11, 2009
 /s/ Timothy P. Walbert
    
    /s/ Robert J. De VaereTimothy P. Walbert
    
    Robert J. De VaerePresident and Chief Executive Officer
    
    Senior Vice President, Finance and Administration
and Chief Financial Officer
 
 1
    
    This certification accompanies the Form 10-Q to which
it relates, is not deemed filed with the Securities and Exchange Commission and
is not to be incorporated by reference into any filing of IDM Pharma, Inc.
under the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Form 10-Q),
irrespective of any general incorporation language contained in such filing.
##### 



EXHIBIT 99.1

CERTIFICATIONS

On
March 26, 2003, Questcor Pharmaceuticals, Inc. filed its Annual Report
on Form 10-K for the year ended December 31, 2002 (the Form 10-K) with the
Securities and Exchange Commission. Pursuant to 18 U.S.C. § 1350, as created
by Section 906 of the Sarbanes-Oxley Act of 2002, the following certifications
are being made to accompany the Form 10-K:

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of Questcor
Pharmaceuticals, Inc. (the Company) hereby certifies, to such officers
knowledge, that:

(i)     the Annual Report on Form 10-K of the Company for the year ended December
31, 2002 (the Report) fully complies with the requirements of Section 13(a)
or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
amended; and

(ii)     the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

|                      |  |                                                                      
|--------------------- |  | ---------------------------------------------------------------------
|Dated: March 26, 2003 |  | /s/ Charles J.
Casamento
Charles J. Casamento
Chief Executive Officer

The foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before
or after the date hereof, regardless of any general incorporation language in
such filing.

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of Questcor
Pharmaceuticals, Inc. (the Company) hereby certifies, to such officers
knowledge, that:

(i)     the Annual Report on Form 10-K of the Company for the year ended December
31, 2002 (the Report) fully complies with the requirements of Section 13(a)
or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
amended; and

(ii)     the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

|                      |  |                                                                
|--------------------- |  | ---------------------------------------------------------------
|Dated: March 26, 2003 |  | /s/ Timothy E. Morris
Timothy E. Morris
Chief Financial Officer

The foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before
or after the date hereof, regardless of any general incorporation language in
such filing.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2695 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2695

          To suspend temporarily the duty on N-Vinylformamide.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 2, 2009

   Mr. Burr introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To suspend temporarily the duty on N-Vinylformamide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. N-VINYLFORMAMIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      N-Vinylformamide    Free         No change        No change        On or before 12/  ''.
                        (CAS No. 13162-05-                                                 31/2011.......
                        5) (provided for
                        in subheading
                        2924.19.11)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
The Schedule contains summary financial information extracted from the 
financial statements for Eagle Insured L.P. and is qualified in its entirety 
by reference to such financial statements
</LEGEND>
<CIK> 0000821203
<NAME> EAGLE INSURED L.P.
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                       1,296,497
<SECURITIES>                                         0
<RECEIVABLES>                               30,849,577
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 3,314
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              33,074,170
<CURRENT-LIABILITIES>                          166,598
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  32,907,572
<TOTAL-LIABILITY-AND-EQUITY>                33,074,170
<SALES>                                              0
<TOTAL-REVENUES>                               697,873
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                60,436
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                637,437
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   637,437
<EPS-PRIMARY>                                      .22
<EPS-DILUTED>                                        0
        


</TABLE>
-  Home 
        -  Health Information 
        -  Healthy Moments Radio Broadcast 
        -  Healthy Moments Episodes 
        -  Don't Let the Holiday Weigh You Down  

Healthy Moments Episodes
-  Don't Let the Holiday Weigh You Down  

**@NIDDKgov on X**RSS Feed

# Don't Let the Holiday Weigh You Down

Healthy Moments Episode:Dec. 25, 2023
Research suggests that many people never lose the extra weight they gain over the holidays.

Listen Now

Download the MP3 audio file(MP3, 1.85 MB)**

## Transcript

**DR. RODGERS:** You’ve heard the phrase easy come, easy go. When it comes to holiday weight gain, don’t expect the weight to go as easily as it came.

Hi, I’m Dr. Griffin Rodgers, director of the National Institute of Diabetes, Digestive, and Kidney Diseases at NIH.

Research suggests that many people never lose the extra weight they gain over the holidays. My colleague, Dr. Susan Yanovski, points out:

**DR. YANOVSKI:**While the average person gains less than one pound between Thanksgiving and New Year’s, many may never lose that weight, and over the years, those pounds add up. You don’t have to gain weight. Healthy eating and physical activity can help you avoid extra pounds over the holidays.

**DR. RODGERS:** If you did gain weight, the New Year is a great time to get more active and eat healthy. By losing weight over time, you can lower your risk for type 2 diabetes and other health problems. 

For more information, follow us @NIDDKgov. This is Dr. Griffin Rodgers with the NIH.

## Related Information

- Keep Active and Eat Healthy to Improve Well-being and Feel Great
- Eating & Physical Activity to Lose or Maintain Weight
- Tips for Starting Physical Activity

Share this page
FacebookXEmailWhatsAppLinkedInRedditPinterest
[Federal Register Volume 74, Number 104 (Tuesday, June 2, 2009)]
[Notices]
[Page 26482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12734]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of the Area 7 Taxpayer Advocacy Panel (Including the 
States of Alaska, California, Hawaii, and Nevada)

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Area 7 Taxpayer Advocacy Panel will be 
conducted. The Taxpayer Advocacy Panel is soliciting public comments, 
ideas, and suggestions on improving customer service at the Internal 
Revenue Service.

DATES: The meeting will be held Wednesday, July 15, 2009.

FOR FURTHER INFORMATION CONTACT: Janice Spinks at 1-888-912-1227 or 
206-220-6098.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to Section 
10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) 
that a meeting of the Area 7 Taxpayer Advocacy Panel will be held 
Wednesday, July 15, 2009, at 2 p.m. Pacific Time via telephone 
conference. The public is invited to make oral comments or submit 
written statements for consideration. Due to limited conference lines, 
notification of intent to participate must be made with Janice Spinks. 
For more information please contact Ms. Spinks at 1-888-912-1227 or 
206-220-6098, or write TAP Office, 915 2nd Avenue, MS W-406, Seattle, 
WA 98174 or post comments to the Web site: http://www.improveirs.org.
    The agenda will include various IRS issues.

    Dated: May 27, 2009.
Shawn F. Collins,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. E9-12734 Filed 6-1-09; 8:45 am]
BILLING CODE 4830-01-P